Citation: Tg. Sagar et al., IMPACT OF HIGH-DOSE CYTOSINE-ARABINOSIDE IN POOR-PROGNOSIS ACUTE LYMPHOBLASTIC-LEUKEMIA - CANCER INSTITUTE EXPERIENCE, CHENNAI, INDIA, Pediatric hematology and oncology, 15(4), 1998, pp. 317-323
Authors:
SHANTA V
MAITREYAN V
SAGAR TG
GAJALAKSHMI CK
RAJALEKSHMY KR
Citation: V. Shanta et al., PROGNOSTIC VARIABLES AND SURVIVAL IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIAS - CANCER INSTITUTE EXPERIENCE, Pediatric hematology and oncology, 13(3), 1996, pp. 205-216
Authors:
GILES FJ
AVVISATI G
SUPANDIMAN I
WICKHAM NR
SUH C
SUHARTI C
MUTHALIB A
TAN P
LEE CH
KUCHOPILLAI V
HARRYANTO A
LEKHAKULA A
RAPOPORT BL
SAGAR TG
AKAN H
RAAFAT J
USKENT N
PARIKH PM
SALIM KA
RADHESHYAM D
RUFF P
HO CH
CHEN YC
SUWANSELA N
KANG JH
SMRUTI BK
PATEL M
KIM SY
TIAN D
THAMPRASIT T
LEE KB
GONZAGA M
SUMANTRI R
NARCISO C
WANG PN
CHASEN MR
RAATS JI
CHAO TY
ANGGRAENI E
RAGNUHARDI D
ONA N
GOPAL BK
COMIA S
FUERST MP
LIM SW
FRANCO MM
KUSUANCO DA
Citation: Fj. Giles et al., COMPARISON OF INITIAL CLINICAL CHARACTERISTICS BETWEEN ASIAN AND ITALIAN MULTIPLE-MYELOMA (MM) PATIENTS ENTERING THE INTERNATIONAL ONCOLOGYSTUDY-GROUP (IOSG) MM1 AND THE ITALIAN MM STUDY-GROUP PROTOCOLS, Blood, 88(10), 1996, pp. 3586-3586